The Board of Directors of Bafna Pharmaceuticals Limited at their meeting held on June 26, 2023. Based on the recommendations of Nomination and Remuneration Committee of Board of Directors, have interalia discussed and approved the appointment of following directors: Mr. Vinayak Dinesh Dendukuri (DIN: 07601309) as Additional Director designated as Whole-time Director - Operation. Mr. Upendar Mekala Reddy (DIN: 08898174) as Additional Director designated as Non- Executive Non-independent Director; Mr. Krishna Yeachuri (DIN: 00066898) as Additional Director designated as Non-Executive Independent Director.

Mr. Vinayak is the Co-founder & Director of NOVICK Biosciences, is also a Director of Brane Enterprises. Mr. Vinayak also served as a Scientist in several positions at Sanofi Pasteur and GlaxoSmithKline, USA. He completed his Bachelor's in Biotechnology from Rochester Institute of Technology, USA, and his Master's in Microbiology, Immunology, and Biochemistry from the University of Rochester, USA.

Mr. Upendar is an Investment Manager at iLabs Group. He holds MBA Degree with specialisation in finance from Indian Institute of Management Kozhikode (IIMK), Bachelor of Technology in Computer Science Engineering from JNTU - Hyderabad. Upendar has over 15 years of experience spanning project and structured finance, fund raising, Mergers and Acquisitions and Investment Banking.

He has executed transactions across sectors including Power (Renewable & Non-renewable), Pharmaceuticals, Roads, Manufacturing, Cement, Real estate, Ports, etc. Mr. Krishna Yeachuri is Commerce Graduate and Chartered Accountant, A Strategic advisor since January 2010 on Business growth, Corporate restructuring, Acquisitions, Business Integration and Transition, arranging Private Equity, Debt financing and other Financing requirements through varied Financing instruments and deals. Worked with reputed companies such as Coromandel Fertilizers Ltd, DCL Polyesters Ltd, GCI SA - a Belgium company, RA Chempharma (part of Advent now), Aurore Life Sciences and currently advising i-labs group of companies.